Advanz for Europe (excl. Nordics) and Israel; Unimedic for Nordics; Hikma for MENA region, Knight Grupo Biotoscana for Latin America; Avir for Canada, CR Gosun for China, JSC Lancet for Eurasian Economic Union; Innoviva Specialty Therapeutics (US; only community acquired bacterial pneumonia)